Skip to main content
. 2024 Dec 17;25(24):13509. doi: 10.3390/ijms252413509

Table 5.

Viability of RHE cells for test tripeptides. Values are an average of three independent measurements.

Peptide CVL CSF CSN PC NC
Viability [%] ± SD 77.8 ± 19.9 a,b,c 90.7 ± 13.7 d 102.2 ± 2.4 a,e 6.2 ± 0.6 c,d,e,f 100.0 ± 0.8 b,f

The same subscripts indicate significant differences between samples (a,bp < 0.05; c,d,e,fp < 0.0001).